{"database": "lobbying", "table": "lobbying_activities", "rows": [[3140763, "9901c974-9530-4210-a8ee-c8a75fc674da", "Q1", "2359 STRATEGIES", 401106114, "TRAVERE THERAPEUTICS", 2024, "first_quarter", "MED", "Rare kidney disease", "HOUSE OF REPRESENTATIVES,SENATE", 0, 0, "2024-04-08T20:03:07-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["3140763"], "units": {}, "query_ms": 0.43340399861335754, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}